Motegrity
Motegrity

1.56
A clinical formulation indicated for Digestive Health. This medication supports natural intestinal motility to alleviate chronic constipation and discomfort related to bowel movement.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Prucalopride
Reference Brand
Prucalopride
Product Origin
Generic Alternative
Reference Manufacturer
Takeda Pharmaceutical
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Digestive Health
Product Category
Prokinetic Agent
Pharmacological Class
Prokinetic agent
Clinical Indications
Manufacturer Description
A prokinetic medication intended to manage chronic idiopathic constipation and designed to alleviate bowel irregularity to support consistent digestive function.
Mechanism of Action
It selectively stimulates 5-HT4 receptors in the gut. This triggers the release of neurotransmitters that increase colonic peristalsis and accelerate transit.
Route of Administration
Oral
Onset Time
24 hours
Duration
24 hours
Contraindications
Bowel perforation, Intestinal obstruction, Severe inflammatory bowel disease, Severe renal impairment
Severe Adverse Events
Suicidal thoughts/behaviors, Ischemic colitis, Severe allergic reaction
Common Side Effects
Headache, Nausea, Abdominal pain
Uncommon Side Effects
Diarrhea, Dizziness, Fatigue, Vomiting
Drug Interactions
Erythromycin, Ketoconazole
Pregnancy Safety Warnings
Not recommended during pregnancy.
Age Restrictions
For adult use.
Storage Guidelines
Store at room temperature in a dry place.
Related Products
Linaclotide, Lubiprostone
Information for Motegrity is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories